KDIGO 2024 Clinical Practice Guideline for CKD Evaluation and Management

Zusammenfassung

CKD Evaluation and Management KDIGO Back CKD Evaluation and Management PLEASE NOTE While the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD remains the current global standard, a focused update to “ Chapter 3: Delaying CKD progression and managing its complications ” is currently underway to address emerging evidence on SGLT2 inhibitors, GLP-1-based therapies, and nonsteroidal mineralocorticoid receptor antagonists in people with CKD without diabetes. Read the ne

Kerninformationen

, evidence-based recommendations for healthcare professionals, patients, caregivers, and policymakers worldwide. Key topics include CKD classification and risk assessment, management of complications, medication stewardship, and patient-centered care across diverse clinical settings. Treatment appro...

research agenda to advance the evidence base in CKD. Guideline Suite KDIGO 2024 CKD Guideline KDIGO 2024 CKD Guideline Executive Summary KDIGO 2024 CKD Guideline Data Supplement KDIGO 2024 CKD Guideline Slide Set KDIGO 2024 CKD Guideline Key Takeaways Slide Set KDIGO 2024 CKD Guideline Top 10 Takeaw...

CKD Guideline Top 10 Takeaways for Nephrologists: Evaluation (Subtítulos en Español) KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Evaluación KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Management (Subtítulos en Español) KDIGO 2024 CKD Guideline Top 10 Takeaways for ...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen